Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Thermo Fisher Scientific, Symyx Integrate LIMS and ELN Solutions

By R&D Editors | January 24, 2012

Thermo Fisher Scientific, Symyx Integrate LIMS and ELN Solutions

Thermo Fisher Scientific Inc. and Symyx Technologies announced a joint product development effort to provide scientists in the bioanalytical community with a completely automated laboratory workflow by integrating Thermo Scientific Watson LIMS (laboratory information management system) with Symyx Notebook. The integration of the industry-standard Thermo Scientific Watson LIMS with Symyx’s electronic lab notebook (ELN) will give scientists secure and seamless access to experimental data across the laboratory. The automated transfer of information between Watson LIMS and the Symyx Notebook provides a streamlined, compliant workflow for bioanalytical studies.

“The integration of Symyx Notebook with Watson LIMS demonstrates Symyx’s ongoing commitment to powering the electronic laboratory environment with better data correlation, more secure information exchanges and improved end-to-end report generation,” said Trevor Heritage, president of Symyx’s software business unit. “Additional capabilities to explore and report Watson LIMS data with Symyx Isentris will enhance the value of scientific information and optimize the way scientists communicate and collaborate in the lab.”

The integration of Thermo Scientific Watson LIMS with Symyx Notebook enables bioanalytical scientists to drive their existing workflow in Watson LIMS, with the added benefit of performing sample preparation, managing instrument calibration and maintenance and completing the experimental record in Symyx Notebook, all under GLP compliance. The LIMS and ELN integration provides the solution needed to help the bioanalytical laboratory migrate from paper-based systems and manual data transcription processes to fully electronic, automated laboratory workflows, enabling research scientists to eliminate costly and time-consuming manual data manipulation methods, dramatically reduce laboratory errors and improve workflow and data compliance with regulatory requirements. The integrated solution also ensures that all experimental details on projects or studies are authenticated by Watson and documented electronically, allowing scientists to share reports and results with colleagues across the lab or in another location.

Thermo Scientific Watson LIMS is a highly specialized, protocol-driven LIMS for drug metabolism and pharmacokinetic (DMPK) studies, and it is used by 18 of the top 20 global pharmaceutical companies and leading contract research organizations worldwide. Symyx Notebook is a single, multi-disciplinary electronic laboratory notebook for the enterprise that accelerates R&D productivity, improves collaboration, lowers costs and streamlines regulatory compliance.

December 15, 2009

Related Articles Read More >

Why IBM predicts quantum advantage within two years
Aardvark AI forecasts rival supercomputer simulations while using over 99.9% less compute
This week in AI research: Latest Insilico Medicine drug enters the clinic, a $0.55/M token model R1 rivals OpenAI’s $60 flagship, and more
How the startup ALAFIA Supercomputers is deploying on-prem AI for medical research and clinical care
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE